Noninvasive treatments for pelvic prolapse
December 11, 2018, 4:34 pm
POP Medical’s NeuGuide surgical system. Photo: courtesy
In January, we reported that the US FDA granted marketing approval to an Israeli minimally invasive system to treat pelvic organ prolapse (POP), which affects half of all women sometime during their life.
POP Medical Solutions developed the NeuGuide solution in response to mounting calls across the world to ban the controversial use of transvaginal mesh to treat the painful and debilitating condition. POP Medical and Escala Medical, another Israeli company developing a minimally invasive POP solution, could revolutionize this $1 billion medical market.
For over 16 years, ISRAEL21c has brought you the faces and places of Israel every day, spreading the word about Israel to millions of people in virtually every country around the globe. First of its kind, our content is originally researched, written and produced by seasoned experts directly from Israel.
We cannot do this without financial support from people like you. Become a GEM member and enjoy exclusive briefings from our staff and more - for $18 a month.
Read more on: